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INTRODUCTION
Trichomonas vaginalis, the causative pathogen for the most 
prevalent non-viral sexually transmitted disease in humans, 
triggers vaginitis, cervicitis, and urethritis [1]. The impact of T. 
vaginalis, as a model organism of host-parasite interaction has 
been extensively investigated, and multiple interactions be-
tween host receptors and protozoan virulence determinants 
are known to occur [2,3]. A previous study identified several 
antigenic proteins present in the membrane portion of T. vagi-
nalis, which includes α-actinin 2 [4]. Alpha-actinin is a Ca2+-
regulated protein involved in actin cross-linking [5]. Five puta-
tive α-actinin genes were discovered in the databases of T. vagi-
nalis. Among them, T. vaginalis α-actinin 2 (Tvα-actinin 2) was 
investigated, due to its strong reactivity to patients’ sera [6]. 
When the parasite adheres to the host cells and it transforms 
into the amoeboid form, this protein is located close to the 
cell surface showing colocalization with actin.
As the main antigen of T. vaginalis, Tvα-actinin 2 has been 
used to monitor trichomoniasis in populations [7] and to ex-
amine the history of trichomoniasis in plasma samples of 
male patients [8]. Reactive epitopes of Tvα-actinin 2 have been 
finely mapped using sera from both male and female patients 
with trichomoniasis [9]. In this study, Tvα-actinin 2 was found 
to be secreted from T. vaginalis. We examined a possibility that 
this secreted protein of T. vaginalis plays a role in the modula-
tion of host immune responses using vaginal and prostate epi-
thelial cells as well as mouse dendritic cells (DCs).
MATERIALS AND METHODS
Parasite cultivation
T. vaginalis KT4 [10] was cultivated axenically in Diamond’s 
Trypticase Yeast extracted Maltose (TYM) medium [11] with 
10% horse serum (Gibco BRL, Karlsruhe, Germany). Cultures 
were grown at 37˚C in a 5% CO2, and transferred daily into 
fresh medium.
Bacterial and human cell culture
Escherichia coli BL21 (DE3) were grown at 37˚C in Luria-Ber-
tani medium (0.5% yeast extract, 1% tryptone, 1% NaCl, pH 
7.5) supplemented with ampicillin (100 μg/ml) in order to 
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Tvα-actinin 2, has been used to diagnose trichomoniasis. This study was undertaken to examine the role of Tvα-actinin 2 
as an antigenic molecule to induce immune responses from humans. Western blot analysis using anti-Tvα-actinin 2 anti-
bodies indicated its presence in the secreted proteins of T. vaginalis. ELISA was employed to measure cytokine produc-
tion by vaginal epithelial cells, prostate cells, mouse dendritic cells (DCs), or T cells stimulated with T. vaginalis or Tvα-
actinin 2 protein. Both T. vaginalis and rTvα-actinin 2 induced cytokine production from epithelial cell lines, including IL-
10. Moreover, CD4+CD25- regulatory T cells (Treg cells) incubated with rTvα-actinin 2-treated DCs produced high levels of 
IL-10. These data indicate that Tvα-actinin 2 modulates immune responses via IL-10 production by Treg cells.
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maintain the plasmids. Medium components were obtained 
from BD-Difco (Franklin Lakes, New Jersey, USA), and the 
chemicals and antibiotics were purchased from Sigma-Aldrich 
(St. Louis, Missouri, USA).
Human vaginal epithelial cells (VECs, ATCC CRL-2614, 
American Type Culture Collection, Manassas, Virginia, USA) 
were grown in Dulbecco’s Modified Eagle’s Medium (Gibco 
BRL) complemented with 10% heat-inactivated fetal bovine se-
rum (FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin. 
Human prostatic epithelial cells (RWPE-1, ATCC CRL-11609, 
ATCC) were grown using Keratinocyte Serum Free Medium 
(Gibco BRL) containing 0.2 ng/ml epidermal growth factor 
and 0.05 mg/ml bovine pituitary extract, 5% FBS, 100 U/ml 
penicillin, and 100 μg/ml streptomycin. These human epitheli-
al cells were cultured to 80-90% confluence at 37˚C/5% CO2.
Formation of Tvα-actinin 2-specific antibodies (Abs)
Full-length recombinant Tvα-actinin 2 (rTvα-actinin 2) was 
prepared as previously described [12]. rTvα-actinin 2 was used 
as antigen to produce polyclonal Abs via intraperitoneal injec-
tion into pathogen-free rats (CrjBgi: CD[SD]IGS, 7-week-old, 
female). After 3 time injections at 2-week intervals, sera were 
obtained from immunized rats, and the titer of the resultant 
Abs was tested.
Preparation of secreted proteins and western blot analysis
Secretomes were prepared from VECs, T. vaginalis trophozo-
ites, and VECs incubated with T. vaginalis at a multiplicity of 
infection (MOI) of 5. VECs were seeded in 12-well culture 
plates (1× 105 cells/well), and then incubated overnight at 5% 
CO2 and 37˚C. T. vaginalis washed with phosphate buffered sa-
line (PBS: 1.7 mM KCl, 137 mM NaCl, 2 mM KH2PO4, and 10 
mM Na2HPO4, pH 7.3) were resuspended in the TYM media 
without serum. After 6 h-incubation of VEC with and T. vagi-
nalis at a MOI of 5, the cells were removed by 20-min centrifu-
gation at 1,200 g, and the collected secretomes were concen-
trated using a Centricone (Milipore, Darmstadt, Germany). 
Ten micrograms of secreted proteins were separated by 10% 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE), and transferred to a polyvinnylidene fluoride 
membrane (Millipore). The membrane was incubated with 
anti-rTvα-actinin 2 Abs (1:1,000 dilution) and subsequently 
with horseradish peroxidase (HRP)-conjugated mouse anti-rat 
IgG (1:1,000 dilution). Immunoreactive bands were visualized 
using an Enhanced Chemiluminescence (ECL) System (GE 
Healthcare, Chicago, Illinois, USA).
Determination of cytokine concentration
A sandwich ELISA was performed to determine the levels of 
TNF-α, IL-12, IL-6, and IL-10 in culture supernatants (BD Bio-
sciences, Franklin Lakes, New Jersey, USA). The levels of cyto-
kines were determined by monitoring the absorbance at 450 
nm, and the cytokine concentrations were calculated based on 
the standard curves generated using recombinant cytokines.
To examine whether cytokine production in rTvα-actinin 
2-induced VECs was caused by contamination with lipopoly-
saccharide (LPS) in the prepared rTvα-actinin 2, endotoxin 
level of rTvα-actinin 2 was measured using the Limulus Ame-
bocyte Lysate LPS Detection Kit (Lonza, Basel, Switzerland). In 
addition, rTvα-actinin 2 were purified using the Detoxi-GelTM 
Endotoxin Removing Gel (Pierce, Rockford, Illinois, USA) be-
fore it was challenged to the host cells for measurement of cy-
tokine production.
Experimental mice
BALB/c mice (6 week-old females) were purchased from Ori-
entBio (Seongnam, Korea). Mice received care according to our 
institutional guidelines and the legal requirements of Korea.
Preparation of DCs
Mouse bone-marrow cells isolated from the tibia and femur 
of mice, were resuspended in red blood cell lysis buffer (10 
mM KHCO3, 150 mM NH4Cl, and 1 mM EDTA, pH 7.4). The 
cells were differentiated into bone marrow-derived dendritic 
cells (BMDCs) in RPMI1640 medium (Gibco BRL) containing 
1 mM HEPES buffer, 20 ng/ml granulocyte-macrophages colo-
ny-stimulating factor (Peprotech, Rocky Hill, New Jersey, 
USA), 100 U/ml penicillin/streptomycin (Gibco BRL), 10% 
FBS, 50 μM mercaptoethanol, and 0.1 mM nonessential ami-
no acid (Sigma-Aldrich). The medium for these cells were re-
placed with the fresh one every 2 days, and the cultures were 
maintained at 37˚C/5% CO2 until day 6 or 7. 
Flow cytometric analysis of cell surface markers
Immature BMDCs were converted into mature cells by incu-
bation with LPS for 16 hr. Mature DCs were harvested, and 
then reacted with rTvα-actinin 2 for additional 16 hr. The cells 
were then stained for 20 min on ice using the Live/dead Fix-
able Dead Cell Stain Kit (Invitrogen, Carlsbad, California, 
USA) to monitor their viability. Following 3 washes with PBS, 
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the cells were reacted with one of these chemicals [allophyco-
cyanin (APC)-conjugated anti-CD80, and phycoerythrin (PE)-
conjugated anti-CD86, and peridinin chlorophyll (PerCP)-Cy 
5.5-conjugated anti-mouse I-A/I-E for MHC class II] along 
with APC-eFluor780-conjugated anti-CD11c for 20 min. After 
3 PBS-washes, the cells were prepared in 500 μl of PBS con-
taining 1% BSA, and 0.1% sodium azide, and their fluores-
cence was measured by flow cytometry. The data analyses were 
performed using FlowJo data analysis software (FlowJo LLC, 
Ashland, Oregon, USA). 
Assays of BMDC-dependent Treg differentiation
Naive T cells were obtained from the draining lymph nodes 
of mice. From the prepared cells in RBC buffer, CD4+CD25+ or 
CD4+CD25- regulatory T cells were prepared using CD4+ 
CD25+ Regulatory T cell Isolation Kit (Miltenyi Biotec, Auburn, 
California, USA) as directed by the manufacturer’s instruc-
tions. The isolated CD4+CD25+ or CD4+CD25- regulatory T 
cells were monitored for the expression of Tregs markers, 
FOXP3, CD103, CD39, and CD152 (CTLA-4) using specific Abs. 
LPS-stimulated DCs (1× 104 cells/well) incubated with 0.1 
μg/ml of rTvα-actinin 2 for 3 h were co-cultured with CD4+ 
CD25+ or CD4+CD25- regulatory T cells (1× 105) at a DC: T cell 
ratio of 1:10. On day 7 of co-culture, supernatants were col-
lected and assayed for IL-10, TGF-α, IFN-γ, IL-4, and IL-2 pro-
duction by ELISA (BD Biosciences). As a control, PBS-treated 
DCs was also assayed for these cytokines. 
Statistical analyses
Data were indicated as the means± SD obtained from 3 in-
dependent experiments. Statistical analysis of pairwise com-
parison was carried out using Student’s t-test (SYSTAT pro-
gram, SigmaPlot version 9, Systat Software Inc., San Jose, Cali-
fornia, USA). Differences were considered statistically mean-
ingful if the P-values were< 0.05. 
RESULTS
Secretion of Tvα-actinin 2 by T. vaginalis 
In this study, rTvα-actinin 2 protein was used as an antigen 
to immunize rats to make anti-Tvα-actinin 2 antibodies. Using 
Abs specific to rTvα-actinin 2, western blot analysis was per-
formed to examine the presence of Tvα-actinin 2 in secreted 
proteins by T. vaginalis (Fig. 1B). Secretomes were prepared 
from VECs (Fig. 1A, B, lane 1) or T. vaginalis (Fig. 1A, B, lane 2). 
In addition, secreted proteins were also collected from T. vagi-
nalis incubated with VECs (Fig. 1A, B, lane 3). No immunore-
active protein was observed in the western blot analysis of the 
secretome derived from VECs. In contrast, an immunoreactive 
protein of 124 kDa was clearly detected in the secretome from 
T. vaginalis, which is an expected size of Tvα-actinin 2. The 
same reactive protein was observed in the secretomes of the 
VECs incubated with T. vaginalis (Fig. 1B). No obvious differ-
ence was detected in the amount of this immunoreactive pro-
tein between T. vaginalis and T. vaginalis incubated with VECs. 
Fig. 1. Secretomes from VECs (lane 1), T. vaginalis (lane 2), or VECs incubated with T. vaginalis (lane 3). Ten µg of secreted proteins was 
separated by 10% SDS-PAGE, and visualized by Coomassie staining (A). They were also incubated with anti-rTvα-actinin 2 Abs (1:1,000 
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Cytokine production in VEC and RWPE-1 cells incubated 
with T. vaginalis
We investigated whether T. vaginalis trophozoites induced 
cytokine production in VEC and RWPE-1, primary target cells 
that T. vaginalis may encounter in vivo (Fig. 2). 
A 16-hr incubation of VECs with T. vaginalis at MOIs of 10 
and 50 triggered the secretion of IL-10, IL-12, and IL-6, and 
TNF-α. The induction of IL-6 production by T. vaginalis oc-
curred up to 770± 39 pg/ml, whereas the amount of TNF-α 
was 250± 2 pg/ml at an MOI of 50 of T. vaginalis. When VECs 
were stimulated with T. vaginalis at an MOI of 50, the levels of 
released IL-10 and IL-12 were 450± 62 and 330± 15 pg/ml, re-
spectively. The levels of TNF-α and IL-12 were proportional to 
the MOI of T. vaginalis. 
RWPE-1 cells were also stimulated with T. vaginalis at MOIs 
of 10, and 50, and then assayed for cytokine production. Simi-
lar levels of TNF-α, IL-10, IL-12, and IL-6 were released from 
RWPE-1 cells by T. vaginalis at levels of 140–510 pg/ml. The in-
duced levels of these 4 cytokines were increased at a higher 
MOI of T. vaginalis.
Cytokine production in VEC and RWPE-1 cells stimulated 
with rTvα-actinin 2
In this experiment, we examined whether rTvα-actinin 2 in-
duces cytokine production in vaginal and prostate epithelial 
cell lines (Fig. 3A, B, respectively). To exclude a possibility that 
contaminated LPS in purified rTvα-actinin 2 induced cytokine 
production, the recombinant protein was further purified us-
ing Endotoxin Removing Gel before it was challenged to the 
host cells. The endotoxin level of rTvα-actinin 2 was 0.8 EU/
ml, which is lower than 2.5 EU/ml, the value indicating con-
tamination. 
When VECs were treated with rTvα-actinin 2 (10 μg/ml), all 
4 cytokines (TNF-α, IL-10, IL-12, and IL-6) were released rang-
ing from 160± 8 to 730± 35 pg/ml. Comparable amount of 
cytokines was produced in the rTvα-actinin 2-exposed RWPE-
1 with VECs.
rTvα-actinin 2 induces a tolerogenic profile in DCs by 
down-regulating the surface molecule and increasing  
IL-10 production
Since the rTVα-actinin-treated host cells produced immuno-
Fig. 2. Cytokine production induced by T. vaginalis in VECs (A) and RWPE-1 (B). VEC or RWPE-1 cells (1×106 cells per well) were incu-
bated in growth medium without antibiotics overnight and incubated with T. vaginalis trophozoites at MOIs of 10 or 50 for 16 hr. Cell-free 
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suppressive cytokines as well as pro-inflammatory cytokines, 
we focused on the function of tolerogenic dendritic cells 
(tDCs) which can induce and control immune tolerance via 
differentiation of regulatory T cells (Tregs). 
A set of mouse BMDCs was treated with LPS (1 μg/ml), and 
then incubated with 0.1 μg/ml rTvα-actinin 2 for 24 h. Anoth-
er set of mouse BMDCs was treated with 0.1 μg/ml rTvα-
actinin 2 for 24 h without LPS treatment. As a control, mouse 
BMDCs were treated with PBS instead of rTvα-actinin 2. The 
expression of DC activation markers, CD80, CD86, and MHC 
class II, was monitored in these cells using their specific anti-
bodies (Fig. 4A). Each set of BMDCs was incubated with iso-
type IgG as a control. All 3 DC activation markers showed in-
creased expression in response to LPS treatment. The expres-
sion of CD80 and CD86 was not significantly altered by an 
additional treatment with rTvα-actinin 2. Interestingly, expres-
sion of MHC II decreased dramatically [from 1,762± 11 to 
915± 250 Mean Fluorescence Intensity (MFI)] with an addi-
tional challenge of rTvα-actinin 2. This result indicated that T. 
vaginalis α-actinin 2 down-regulates LPS-induced DC activa-
tion as shown by the decrease in MHC II expression.
Mouse BMDCs were stimulated with rTvα-actinin 2 (0.1 μg/
ml), and then assayed for IL-10, IL-12, and IL-6 levels (Fig. 
4B). While the levels of IL-12 and IL-6 in LPS-challenged DCs 
were decreased by rTvα-actinin 2 treatment, IL-10 production 
was further increased by rTvα-actinin 2 in LPS-treated DCs. IL-
10 plays an anti-inflammatory role to prevent inflammatory 
pathologies [13]. 
rTvα-actinin 2 produces IL-10 in effector T lymphocytes 
by generation of regulatory molecules 
In this experiment, we examined whether IL-10 is induced 
in regulatory T cells upon co-incubation with rTva-actinin 
2-treated DCs. The regulatory T cells isolated from the spleen 
and draining lymph nodes of mice were further sub-fraction-
ated into natural Tregs (nTregs; CD4+CD25+) and inducible 
Tregs (iTregs; CD4+CD25-). When the obtained CD4+CD25- T 
cells were co-incubated with LPS-stimulated mouse BMDCs 
treated with rTvα-actinin 2, they secreted a high level of IL-10 
(825 pg/ml) compared to the cells incubated with LPS-stimu-
lated DCs (9 pg/ml) (Fig. 5A). In addition, these cells secreted 
a high level of TGF-β (585 pg/ml) and IFN-γ (1,000 pg/ml) 
Fig. 3. Cytokine production induced by Tvα-actinin 2 in VECs (A) and RWPE-1 (B). VEC or RWPE-1 cells (1×106 cells per well) were incu-
bated in growth medium without antibiotics overnight and incubated with 10 μg/ml rTvα-actinin 2 for 16 hr. As a positive control, the cells 
were treated with 10 μg/ml LPS for 16 hr. Cell-free supernatants were collected, and the levels of IL-10, IL-12, IL-6, and TNF-α were de-
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Fig. 4. Cytokine production and expression of co-stimulatory and MHC II molecules by rTvα-actinin 2-stimulated mouse DCs. Mouse 
bone-marrow cells prepared from the femur and tibia of BALB/c mice were differentiated into DCs. On day 7, immature BMDCs (1×106 
cells/ml) were stimulated with rTvα-actinin 2 (0.1 μg/ml) for 16 hr. Another set of cells were pre-treated with E. coli LPS (Sigma) at 0.5 µg/
ml in addition to rTvα-actinin 2. (A) Cells were harvested and then stained with PerCP-Cy 5.5-conjugated anti-mouse I-A/I-E (MHC class 
II), APC-conjugated anti-CD80, and PE-conjugated anti-CD86 along with APC-eFlour780-conjugated anti-CD11c for 20 min on ice. Flu-
orescence was measured by flow cytometry, and data were analyzed using FlowJo data analysis software. Isotype controls are shown 
as shaded histograms, control BMDCs are shown as blue lines, and rTvα-actinin2 stimulated BMDCs are shown as red lines. Bar 
graphs shows surface markers as indicated as MFI of 3 independent experiments in which 3 mice were used to get BMDCs. (B) Cell-
free supernatants were collected, and assayed for IL-10, IL-12, and IL-6 using ELISA kits. The negative control was supernatant of 
mouse immature DCs that were not stimulated. The assays were repeated 3 times. Each experiment was performed with a single 
mouse and the ELISA was performed in triplicate. A representative experiment is shown. Results are expressed as the mean±SD of the 
triplicate of the representative experiment. Statistical analyses for pair-wise comparisons were performed using Student’s t-tests to eval-
uate the statistical significance of these results. Differences with P-values of less than 0.05 were considered significant. Data with P-val-
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Fig. 5. rTvα-actinin 2 induce the expression of a regulatory T cell profile in effector T cells. Mouse DCs treated with LPS were exposed to 
rTvα-actinin 2 and then incubated with mouse CD4+CD25+ or CD4+CD25- T cells. (A) Suppressive activity was determined by ELISA to 
measure IL-10, TGF-β, and IFN-γ secretion in the culture supernatants. Low/negative secretion was determined by IL-4 and IL-2 secre-
tion in the culture supernatants. Figures are means of 3 independent experiments with 3 mice for each experiment. (B) CD4+CD25+ or 
CD4+CD25- lymphocytes were phenotyped by flow cytometry with PE-conjugated anti-CD25 and these populations were subsequently 
analyzed for expression of FoxP3, CD103, CD39, and CTLA-4. CD4+CD25+ or CD4+CD25- lymphocytes (1×105 cells/ml) were isolated 
from the spleen and draining lymph nodes of PBS or rTvα-actinin 2 incubated mouse BMDCs for 7 days co-incubation. Values marked 
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only when they were co-incubated with LPS-stimulated DCs 
treated with rTvα-actinin 2. On the contrary, iTregs co-incubat-
ed with LPS-stimulated DCs treated with rTvα-actinin 2 did 
not release IL-4 or IL-2. On the other hand, nTregs secreted 
various amount of these cytokines ranging from 45 to 1,746 
pg/ml when co-incubated with treated rTvα-actinin 2 of LPS-
stimulated DCs. Except TGF-α, showing increased secretion af-
ter rTvα-actinin 2 treatment, nTregs demonstrated no altera-
tion in cytokine levels in response to rTvα-actinin 2. 
These Tregs were co-incubated with DCs treated only with 
LPS or DCs treated with LPS and rTvα-actinin 2, and the ex-
pression of FoxP3, CD103, CD39, and CTLA-4 was determined 
(Fig. 5B). The expression of Treg markers such as FoxP3, 
CD103, CD39, and CTLA-4 was not significantly changed by 
an additional treatment of LPS-stimulated mouse BMDCs 
with rTvα-actinin 2 in the CD4+CD25+ cells. In case of CD4+ 
CD25- cells, the expression of 3 markers, CD103, CD39, and 
CTLA-4, was increased upon co-incubation with rTvα-actinin 
2-treated DCs compared with that in cells co-incubated with 
the untreated DCs. On the contrary, FoxP3 level was not 
changed by rTvα-actinin 2 treated DCs. This result suggests 
that rTvα-actinin 2 induced the Treg phenotype in effector T 
lymphocytes. 
DISCUSSION
Since Tvα-actinin 2 was identified as an immunogenic pro-
tein reacting to anti-T. vaginalis IgGs of female patients with 
trichomoniasis [7], it has even been used to monitor men’s se-
rological samples for trichomoniasis exposure and risk of 
prostate cancer [8]. Recently, this protein was finely mapped 
for epitopes reactive to patients’ sera from only females or 
from both males and females [9]. To be functional with re-
spect to host interaction, this protein in the pathogen should 
be secreted or be present on its outermost surface. In this 
study, Tvα-actinin 2 was found in the secretome of T. vaginalis 
(Fig. 1B) and its secretion was not affected by the presence of 
the host cells, VECs. Due to the lack of signal sequence in Tvα-
actinin 2, it should be examined how Tvα-actinin 2 is secreted 
from T. vaginalis. However, many proteins lacking signal se-
quences were found to be secreted via exocytosis [14].
In this study, we examined immune responses of the host 
epithelial cells, especially vaginal and prostate cells by measur-
ing cytokine production upon incubation with T. vaginalis as 
well as rTvα-actinin 2 protein (Figs. 2, 3, respectively). Among 
the produced cytokines, IL-10 attracted our attention because 
it is an anti-inflammatory cytokine preventing inflammatory 
pathologies [15]. Therefore, we examined whether rTvα-
actinin 2 plays a role in immunosuppression (Fig. 4), clearly 
indicating that rTvα-actinin 2 modulates DC activation by 
down-regulation of IL-12/up-regulation of IL-10, and inhibi-
tion of LPS-induced maturation of DCs. Secretion of IL-10 by 
tDCs is essential for tolerance in Treg differentiation via several 
different pathways [16].
Several components of T. vaginalis modulate the host im-
mune response. Human neutrophils and macrophages stimu-
lated with T. vaginalis produce IL-8 and the acute proinflam-
matory cytokine IL-6, TNF-α, and IL-1β, thereby initiate the 
immune response to T. vaginalis infection [10,17]. Especially, 
IL-6 is a critical factor of chronic inflammation in prostate can-
cer [18]. A recent study on interaction with prostate epithelial 
cells and T. vaginalis demonstrated increased production of 
IL-6 and epithelial–mesenchymal transition markers [19]. T. 
vaginalis lipophosphoglycan was shown to mediate adhesion 
of these parasites to VECs, and to induce a selective up-regula-
tion of chemotactic cytokines in a TLR4-MyD88-independent 
manner [20]. Screening of T. vaginalis antigens with patients’ 
sera led to the isolation of T. vaginalis enolase which has plas-
minogen binding activity and whose expression is up-regulat-
ed by contact between the parasite and VECs [21]. Our results 
show immunosuppressive characteristics of the infection trig-
gered by T. vaginalis. Expression of IL-12 and TNF-α was sup-
pressed in T. vaginalis–adhesive cells, suggesting that this in-
hibitory mechanism is induced by T. vaginalis to evade host 
immunity [22]. Dying neutrophils by T. vaginalis result in the 
resolution of vaginal inflammation by inducing anti-inflam-
matory cytokine production in human macrophages [23]. In a 
study observing DC activation against various pathogens, for-
malin-fixed T. vaginalis induces only IL-10, but not IL-12 [24]. 
Importantly, excretory-secretory products (ESP) of T. vaginalis 
triggered tolerance as shown the inhibition of LPS-induced 
maturation of DCs [25]. Western blot analysis of T. vaginalis 
ESP with anti-Tvα-actinin 2 revealed that this protein is also 
present in the secreted fraction (Fig. 1B). Therefore, it is likely 
that Tvα-actinin 2 is one of the protozoan molecules function-
ing as an immunosuppressor during trichomoniasis, which 
acts both as a surface and secreted virulence factor. Interesting-
ly, T. vaginalis homolog of macrophage migration inhibitory 
factor, TvMIF was discovered to induce inflammation and cell 
proliferation, thus leading to the progression of prostate can-
 Lee et al.: T. vaginalis α-actinin 2 modulates host immune responses via IL-10  383
cer [26]. Identifying a host receptor for Tvα-actinin 2 would re-
veal the mechanisms underlying this protozoan molecule 
functions as a modulator for host immune systems.
Modulation of DC activity by rTvα-actinin 2 was mediated 
by Treg cells as shown in Fig. 5. IL-10 is known to initiate an 
anti-inflammatory feedback loop by the cooperative action 
with other immune cells [27]. The tDCs activated by IL-10 in 
peripheral tissues, obtain the ability to secrete IL-10, and then 
move to lymphoid organs, a site for Treg differentiation. We 
present evidence that Tvα-actinin 2 could generate iTregs dur-
ing infection. Co-cultivation of Tvα-actinin 2 did not increase 
the levels of IL-10, TGF- β, and IFN-γ in nTregs (CD4+CD25+) 
but increased the levels of IL-10, TGF- β, and IFN-γ in CD4+ 
CD25- T cells. The high surface levels of CD103, CD39, and 
CTLA-4 on T effs (CD4+CD25-) help to contribute to tolerance 
of T. vaginalis infections as a consequence of IL-10 production. 
Additionally, IL-10 is required for the suppressive phenotype 
of Tregs against the inflammatory signals. IFN-γ is a key factor 
for the conversion of CD4+CD25- T cells into iTreg as shown 
in suppressed autoimmunity of the IFN-γ deficient mice [28]. 
Thus, our results demonstrated that rTvα-actinin 2 is respon-
sible for immune tolerance, a characteristic of trichomoniasis 
by modulating the maturation and cytokine production by 
DCs.
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